Scientific article
Open access

Assessment of the Cow's Milk-related Symptom Score (CoMiSS) as a diagnostic tool for cow's milk protein allergy: a prospective, multicentre study in China (MOSAIC study)

Published inBMJ open, vol. 12, no. 2, e056641
Publication date2022-02-17
First online date2022-02-17

Objectives: The MOSAIC study aimed to evaluate if the Cow's Milk-related Symptom Score (CoMiSS) can be used as a stand-alone diagnostic tool for cow's milk protein allergy (CMPA).

Design: Single-blinded, prospective, multicentre diagnostic accuracy study.

Setting: 10 paediatric centres in China.

Participants: 300 non-breastfed infants (median age 16.1 weeks) with suspected CMPA.

Interventions: After performing the baseline CoMiSS, infants commenced a cow's milk protein elimination diet with amino acid-based formula for 14 days. CoMiSS was repeated at the end of the elimination trial. Infants then underwent an open oral food challenge (OFC) with cow's milk-based formula (CMF) in hospital. Infants who did not react during the OFC also completed a 14-day home challenge with CMF. A diagnosis of CMPA was made if acute or delayed reactions were reported.

Primary outcome measures: A logistic regression model for CoMiSS to predict CMPA was fitted and a receiver-operator characteristic (ROC) curve generated. An area under the curve (AUC) of ≥0.75 was deemed adequate to validate CoMiSS as a diagnostic tool (target sensitivity 80%-90% and specificity 60%-70%).

Results: Of 254 infants who commenced the OFC, 250 completed both challenges, and a diagnosis of CMPA made in 217 (85.4%). The median baseline CoMiSS in this group fell from 8 (IQR 5-10) to 5 (IQR 3-7) at visit 2 (p<0.000000001), with a median change of -3 (IQR -6 to -1). A baseline CoMiSS of ≥12 had a low sensitivity (20.3%), but high specificity (87.9%) and high positive predictive value (91.7%) for CMPA. The ROC analysis with an AUC of 0.67 fell short of the predefined primary endpoint.

Conclusions: The present study did not support the use of CoMiSS as a stand-alone diagnostic tool for CMPA. Nevertheless, CoMiSS remains a clinically useful awareness tool to help identify infants with cow's milk-related symptoms.

Trial registration number: NCT03004729; Pre-results.

  • Allergy
  • Community child health
  • Paediatric dermatology
  • Paediatric gastroenterology
  • Allergens
  • Animals
  • Area Under Curve
  • Cattle
  • Child
  • Female
  • Humans
  • Infant
  • Milk
  • Milk Hypersensitivity / diagnosis
  • Prospective Studies
Citation (ISO format)
VANDENPLAS, Yvan et al. Assessment of the Cow’s Milk-related Symptom Score (CoMiSS) as a diagnostic tool for cow’s milk protein allergy: a prospective, multicentre study in China (MOSAIC study). In: BMJ open, 2022, vol. 12, n° 2, p. e056641. doi: 10.1136/bmjopen-2021-056641
Main files (1)
Article (Published version)
ISSN of the journal2044-6055

Technical informations

Creation08/30/2023 5:57:53 AM
First validation10/09/2023 9:09:24 AM
Update time10/09/2023 9:09:24 AM
Status update10/09/2023 9:09:24 AM
Last indexation02/01/2024 10:48:04 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack